New CF drug cocktail enters first human safety tests
Disease control
Recruiting now
This early-stage trial tests the safety of three experimental drugs (SION-451, SION-2222, and SION-109) given together to healthy adults aged 18–55. The study aims to see if the combinations are safe and how the body processes them. It is a first step toward possibly developing a…
Phase: PHASE1 • Sponsor: Sionna Therapeutics Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:20 UTC